Ben Kovler, CEO of Green Thumb Industries, highlights how current federal restrictions stifle growth and capital access for the cannabis sector. He advocates for rescheduling to enable research and expand market opportunities.
- Federal rescheduling could transform the $30B cannabis industry
- Current regulations block access to traditional capital markets
- Strong consumer demand is outpacing regulatory frameworks
- Rescheduling would facilitate expanded medical research
- Policy change would provide better access for veterans
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.